Identification of a neuronal endocytic pathway activated by an apolipoprotein E (apoE) receptor binding peptide

Brain Research

Volumn 778, Issue 1, 1997, Pages 6-15

  Wang, Xiao shu ^a   Ciraolo, Georgianne ^a   Morris, Randal ^a   Gruenstein, Eric ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Ca2+ (i); Apolipoprotein E; Cytoplasmic calcium; Endocytosis; Neuron; Receptor associated protein; Synthetic peptide

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CENTRAL NERVOUS SYSTEM; EMBRYO; ENDOCYTOSIS; IMAGE ANALYSIS; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEINS E; CALCIUM; CELLS, CULTURED; CYTOPLASM; DIPEPTIDES; ENDOCYTOSIS; LDL-RECEPTOR RELATED PROTEIN 1; MICROSCOPY, ELECTRON; MICROSCOPY, VIDEO; MOLECULAR SEQUENCE DATA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LIPOPROTEIN;

EID: 0031555394     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00877-9     Document Type: Article

References (55)

1. Aggerbeck L.P., Wetterau J.R., Weisgraber K.H., Wu C.S.C., Lindgren F.T. Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains J. Biol. Chem. 263:1988;6249-6258.
2. Avila E.M., Holdsworth G., Sasaki N., Jackson R.L., Harmony J.A.K. Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. J. Biol. Chem. 257:1982;5900-5909.
3. Battey F.D., Gafvels M.E., FitzGerald D.J., Argraves W.S., Chappell D.A., Strauss J.F. 3rd., Strickland D.K. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J. Biol. Chem. 269:1994;23268-23273.
4. Betz W.J., Mao F., Bewick G.S. Activity-dependent fluorescent staining and destaining of living vertebrate motor nerve terminals. J. Neurosci. 12:1992;363-375.
5. Boyles J.K., Zoellner C.D., Anderson L.J., Kosik L.M., Pitas R.E., Weisgraber K.H., Hui D.Y., Mahley R.W., Gebicke-Haerter P.J., Ignatius M.J., Shooter E.M. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83:1989;1015-1031.
6. Clay M.A., Anantharamaiah G.M., Mistry M.J., Balasubramaniam A., Harmony J.A.K. Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry. 34:1995;11142-11151.
7. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
8. Curtiss L.K., Forte T.M., Davis P.A. Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation. J. Immunol. 133:1984;1379-1384.
9. Das H.K., McPherson J., Bruns G.A.P., Karathanasis S.K., Breslow J.L. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 260:1985;6240-6247.
10. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
11. Dyer C.A., Curtiss L.K. A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor. J. Biol. Chem. 266:1991;22803-22806.
12. Dyer C.A., Curtiss L.K. Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis. J. Biol. Chem. 263:1988;10965-10973.
13. Dyer C.A., Cistola D.P., Parry G.C., Curtiss L.K. Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor. J. Lipid Res. 36:1995;80-88.
14. Dyer C.A., Smith R.S., Curtiss L.K. Only multimers of a synthetic peptide of human apolipoprotein E are biologically active. J. Biol. Chem. 266:1991;15009-15015.
15. Graham R.C., Karnovsky M.J. The early stages of adsorption of injected horseradish peroxidase in proximal tubules in mouse kidney. Ultra-structural cytochemistry by a new technique. J. Histochem. Cytochem. 14:1966;291.
16. Grill R.J. Jr., Pixley S.K. 2-Mercaptoethanol is a survival factor for olfactory, cortical and hippocampal neurons in short-term dissociated cell culture. Brain Res. 613:1993;168-172.
17. Guillaume D., Bertrand P., Dea D., Davignon J., Poirier J. Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: isoform-specific alterations. J. Neurochem. 66(6):1996;2410-2418.
18. Hallman D.M., Boerwinkle E., Saha N., Sandholzer C., Menzel H.J., Csazar A., Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49:1991;338-349.
19. Han S.H., Einstein G., Weisgraber K.H., Strittmatter W.J., Saunders A.M., Pericak-Vance M., Roses A.D., Schmechel D.E. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53:1994;535-544.
20. Handelmann G.E., Boyles J.K., Weisgraber K.H., Mahley R.W., Pitas R.E. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res. 31:1992;1677-1688.
21. Holtzman D.M., Pitas R.E., Kilbridge J., Nathan B., Mahley R.W., Bu G., Schwartz A.L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA. 92:1995;9480-9484.
22. Hui D.Y., Harmony J.A.K., Innerarity T.L., Mahley R.W. Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B. J. Biol. Chem. 255:1980;11775-11781.
23. Ignatius M.J., Gebicke-Harter P.J., Skene J.H.P., Schilling J.W., Weisgraber K.H., Mahley R.W., Shooter E.M. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA. 83:1986;1125-1129.
24. Innerarity T.L., Pitas R.E., Mahley R.W. Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J. Biol. Chem. 254:1979;4186-4190.
25. Kaiser E.T., Kézdy F.J. Amphiphilic secondary structure: design of peptide hormones. Science. 259:1984;249-255.
26. Kaiser E.T., Kézdy F.J. Peptides with affinity for membranes. Annu. Rev. Biophys. Biophys. Chem. 16:1987;561-581.
27. Karnovsky M.J. Use of ferrocyanide-reduced osmium tetroxide in electron microscopy. J. Cell Biol. 51:1971;146a.
28. Kounnas M.Z., Argraves W.S., Strickland D.K. The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330. J. Biol. Chem. 267:1992;21162-21166.
29. Mahley R.W., Rall S.C. Jr., in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic Basis of Inherited Disease, 6th ed., vol. 1, McGraw-Hill, New York, 1989, pp. 1195-1213.
30. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
31. Medh J.D., Fry G.L., Bowen S.L., Pladet M.W., Strickland D.K., Chappell D.A. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 270(2):1995;536-540.
32. Metzger R.E., LaDu M.J., Pan J.B., Getz D.E., Frail G.S., Falduto M.T. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;372-380.
33. Mims M.P., Darnule A.T., Tovar R.W., Pownall H.J., Sparrow D.A., Sparrow J.T., Via D.P., Smith L.C. A nonexchangeable apolipoprotein E peptide that mediates binding to the low density lipoprotein receptor. J. Biol. Chem. 269:1994;20539-20547.
34. Morris R.E., Ciraolo G.M., Caelinger C.B. Validation of the biotinyl ligand-avidin-gold technique. J. Histochem. Cytochem. 40:1992;711-721.
35. Murphy T.H., Blatter L.A., Wier W.G., Baraban J.M. Spontaneous synchronous synaptic calcium transients in cultured cortical neurons. J. Neurosci. 12:1992;4834-4845.
36. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
37. Olaisen B., Teisberg P., Gedde-Dahl T. Jr. The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man. Hum. Genet. 62:1982;233-236.
38. Pepe M.G., Curtiss L.K. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDH-In. J. Immunol. 136:1986;3716-3723.
39. Rall S.C. Jr., Weisgraber K.H., Innerarity T.L., Mahley R.W. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc. Natl. Acad. Sci. USA. 79:1982;4696-4700.
40. Rall S.C. Jr., Weisgraber K.H., Innerarity T.L., Bersot T.P., Mahley R.W., Blum C.B. Identification of a new structural variant of human apolipoprotein E, E2 (Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype. J. Clin. Invest. 72:1983;1288-1297.
41. Rall S.C. Jr., Weisgraber K.H., Mahley R.W. Human apolipoprotein E. The complete amino acid sequence. J. Biol. Chem. 257:1982;4171-4178.
42. Ryan T.A., Reuter H., Wendland B., Schweizer F.E., Tsien R.W., Smith S.J. The kinetics of synaptic vesicle recycling measured at single presynaptic boutons. Neuron. 11:1993;713-724.
43. Shore V.G., Shore B. Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry. 12:1973;502-507.
44. i and secretion-coupled membrane turnover, by single cell fluorescence microscopy. Cell Calcium. 18:1995;440-454.
45. Snipes G.J., McGuire C.B., Norden J.J., Freeman J.A. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc. Natl. Acad. Sci. USA. 83:1986;1130-1134.
46. Sparrow J.T. An improved polystyrene support for solid phase peptide synthesis. J. Org. Chem. 41:1976;1350-1353.
47. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
48. Utermann G., Jaeschke M., Menzel J. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS lett. 56:1975;352-355.
49. 2+ in the cell cycle in human fibroblasts: transitions between G1 and G0 and progression into S phase. Mol. Biol. Cell. 4:1993;293-302.
50. Wang X., Gruenstein E., The rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide, J. Cell Physiol. 173 (1997) 73-83.
51. Weisgraber K.H. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45:1994;249-302.
52. K.H. Weisgraber, S. Lund-Katz, M.C. Phillips, in: O. Stein, S. Eisenberg, Y. Stein (Eds.), Atherosclerosis IX: Proceedings of the Ninth International Symposium on Atherosclerosis, R & L Creative Communications, Tel Aviv, 1992, pp. 29-32.
53. Weisgraber K.H., Rall S.C. Jr., Mahley R.W. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem. 256:1981;9077-9083.
54. Wetterau J.R., Aggerbeck L.P., Rall S.C. Jr., Weisgraber K.H. Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J. Biol. Chem. 263:1988;6240-6248.
55. Zannis V.I., Breslow J.L. Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia. J. Biol. Chem. 255:1980;1759-1762.